Home Tags Regeneron

Tag: Regeneron

Federal court rules in favor of Regeneron in Praluent patent lawsuit

Judge Richard Andrews’ Aug. 28 ruling overturned portions of a jury verdict in February that found Amgen’s patents on its cholesterol drug Repatha were valid. Regeneron and Sanofi sell rival drug Praluent.

Regeneron goes high-tech with ‘smart’ windows

Regeneron has become one of the early adopters in Westchester of smart windows, which use an internal electrochromic coating to control the density of a window's tint.

Regeneron moves closer to European approval of drug for asthma

In the U.S., it is indicated for use by prescription to treat moderate-to-severe atopic dermatitis, also known as eczema.

FDA grants priority review for Regeneron dermatitis drug for adolescents

The announcement this morning came at the same time that Regeneron announced third-quarter net sales for EYLEA (aflibercept) increased 7 percent to $1.02 billion versus third quarter 2017.

Regeneron to expand upstate workforce by 1,500

Regeneron, which is the largest biotech company in the state, has a reported 2,500 workers at the East Greenbush campus outside of Albany.

Regeneron to invest $100M in bluebird bio, team up for cancer...

Regeneron will also collaborate with the company for a five-year period to develop and commercialize novel immune cell therapies for cancer.

Regeneron co-founder talks drug process, importance of science

New York Medical College recently hosted a seminar featuring Dr. George D. Yancopoulos, founding scientist, president and chief scientific officer of the major biotech company.

Mastercard, Regeneron top Westchester companies on Forbes ‘best’ lists

IBM, ITT, PepsiCo, and the New York Power Authority were also cited as among the nation's best employers. Forbes partnered with market research company Statista to compile the lists

FDA to review Regeneron’s cemiplimab for treatment of squamous cell carcinoma

These cancers commonly appear on sun-exposed areas of the body such as the face, ears, neck, lips and backs of the hands.

European agency to review Regeneron-Sanofi drug applications

The European agency will also review the marketing authorization application for cemiplimab, which is used to treat patients with metastatic cutaneous squamous cell carcinoma.

Regeneron dermatitis drug Dupixent approved in Japan

The antibody drug was approved for use in the U,S. last March.

Regeneron collaborates with Dutch company on combined cancer treatment

Regeneron in the agreement has an option to exclusively license an ISA Pharmaceuticals drug that targets cancers linked to a human papilloma virus.

Regeneron, Decibel partner to develop hearing loss therapeutics

Regeneron will provide Decibel with access to its proprietary suite of technologies in order to discover and develop new medicines for hearing loss and tinnitus.

Regeneron holds first global day of service

The company’s employees participated in community service projects impacting nonprofit and community organizations.

Regeneron, Boehringer Ingelheim make magazine’s top employers list

It's the fifth time in six years thatTarrytown's Regeneron has been named the No. 1 workplace.